Sandoz commits to increasing support from one winner to three, following impressive pitches from the finalistsWinning ideas proposed innovative uses of artificial intelligence, mobile apps and digital therapeutics to address healthcare access challenge…
Sandoz has been officially certified by the Top Employers Institute for its exceptional employee offerings globallyThe Top Employers Institute is generally acknowledged as the global authority on recognizing excellence in people practicesThis exclusive…
Full year net sales up 5% (cc[1], +6% USD) driven by strong performance of growth drivers:Pharmaceuticals BU grew 7% (cc) driven by Cosentyx USD 2.8 billion (+36% cc) and Entresto USD 1.0 billion (+102% cc)Oncology BU grew 9% (cc) driven by AAA[2] (USD…
Princeton, New Jersey, January 16, 2019 – Sandoz Inc. (Sandoz), a Novartis division, today announced the US market introduction of SYMJEPI™ (epinephrine) 0.3 mg Injection for the emergency treatment of allergic reactions (Type 1), including anaphylaxis…
Competition generated ideas from more than 400 entrants in 80 countries – three shortlisted entrants from Uganda, the US and the NetherlandsThree finalists shared innovative uses of artificial intelligence, mobile apps and digital therapeutics to addre…
reSET-O(TM)* is the first US FDA-cleared prescription digital therapeutic for patients with Opioid Use DisorderCleared by the FDA in December, reSET-O is available immediatelyAs part of a broader focus on digital healthcare solutions at Novartis, Sando…
Agreement covers biosimilar insulins in early and clinical development for the top three selling branded insulins by sales: glargine, lispro and aspart Over 400 million people worldwide have diabetes and the amount of insulin required to treat type 2 d…
Strategic collaboration agreement with Curetis subsidiary Ares Genetics to develop digital platform for development and life-cycle management of antibioticsProgram will combine established microbiology laboratory techniques with advanced bioinformatics…
reSET-OTM is the first FDA-cleared Prescription Digital Therapeutic (PDT) for patients with Opioid Use Disorder Pear Therapeutics is leading the development of a new therapeutic class with two FDA-authorized PDTs and a robust pipeline of therapeutics a…
Sandoz has been certified by the Top Employers Institute for its exceptional employee offerings in Asia Pacific (APAC)The annual, international research undertaken by the Top Employers Institute recognizes leading employers around the worldThis exclusi…